Esperovax, Ginkgo Bioworks partner to develop RNA-based therapeutics
PLYMOUTH—Esperovax, the Plymouth developer of oral mRNA biologics, and Boston-based Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced a partnership to …